Related Experiment Video
Updated: May 7, 2026

Comparing Objective Conjunctival Hyperemia Grading and the Ocular Surface Disease Index Score in Dry Eye Syndrome During COVID-19
Published on: May 25, 2022
Adjunctive systemic corticosteroids in pediatric orbital cellulitis: a systematic review and meta-analysis
Emily S Acker1, Gabriela Martin Gonzalez1, Dylan Davie1
1College of Medicine, SUNY Downstate Health Sciences University, Brooklyn, NY, United States.
Adjunctive systemic corticosteroids did not shorten hospital stays for pediatric orbital cellulitis. This treatment may increase risks for surgery, pediatric intensive care unit (PICU) admission, and readmission, warranting further research.
Area of Science:
- Pediatric infectious diseases
- Ophthalmology
- Critical care medicine
Background:
- Orbital cellulitis is a severe pediatric infection with potential vision- and life-threatening complications.
- The use of systemic corticosteroids alongside antibiotics for orbital cellulitis in children is common but lacks definitive evidence regarding efficacy and safety.
Purpose of the Study:
- To systematically review and meta-analyze the effectiveness and safety of adjunctive systemic corticosteroids in pediatric patients hospitalized with orbital cellulitis.
Main Methods:
- A PRISMA-compliant systematic review and meta-analysis included randomized and observational studies.
- Studies compared corticosteroid plus antibiotics versus antibiotics alone in children (<21 years).
- Outcomes assessed included length of stay, surgical intervention, PICU admission, and 30-day readmission.
Main Results:
- Six studies (n=11,803) were included; corticosteroid use did not significantly reduce length of stay.
- Corticosteroid use was associated with increased risks of surgery (RR 2.08), PICU admission (RR 1.82), and 30-day readmission (RR 2.53).
- Evidence certainty was low to moderate, primarily due to observational data.
Conclusions:
- Adjunctive corticosteroids in pediatric orbital cellulitis did not demonstrate benefits in reducing hospitalization duration.
- Potential increased risks of adverse outcomes, including surgery and readmission, were observed.
- High-quality pediatric randomized controlled trials are necessary to clarify the role of corticosteroids in managing orbital cellulitis.
More Related Videos
Related Concept Videos
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment
COPD: Management Using Bronchodilators and Corticosteroids
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.

